SCHEMBL5177579

SCHEMBL5177579

S=C1Nc2cc(Cl)ccc2C(c2ccccc2)N1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
KMT2A Q03164 3/20 0.42
GAA P10253 2/20 0.42
TRPM5 Q9NZQ8 3/20 0.41
TRPM4 Q8TD43 2/20 0.41
ALOX12 P18054 1/20 0.41
KIF11 P52732 1/20 0.40
MEN1 O00255 2/20 0.40
KDM4E B2RXH2 2/20 0.40
GLA P06280 1/20 0.40
MAPT P10636 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
DHFR P00374 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
GUSB P08236 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5205016 0.88 ALDH1A1 (0.46) ALDH1A1KMT2AGAATRPM5TRPM4
SCHEMBL5696249 0.86 DHFR (0.51) ALDH1A1KIF11SMN1; SMN2DHFRHTR2A
SCHEMBL5178013 0.81 KMT2A (0.55) ALDH1A1KMT2AGAAALOX12MEN1
SCHEMBL9567855 0.80 ALDH1A1 (0.54) ALDH1A1KMT2AGAAMEN1MAPT
SCHEMBL5176626 0.80 ALDH1A1 (0.54) ALDH1A1KMT2AGAAMEN1MAPT
SCHEMBL5696173 0.76 DHFR (0.50) ALDH1A1KMT2ATRPM5TRPM4ALOX12
SCHEMBL13612701 0.73 ALDH1A1 (0.46) ALDH1A1KMT2AGAAMEN1KDM4E
SCHEMBL29357488 0.72 DHFR (0.54) ALDH1A1KMT2AGAAKIF11MEN1
SCHEMBL5177430 0.72 MAPT (0.50) ALDH1A1KMT2AGAATRPM5ALOX12
SCHEMBL5696233 0.72 DHFR (0.54) ALDH1A1KMT2AGAAKIF11MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807402-A1 QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS ANTIMITOTICS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID DERIVATIVES EMBL (DE) 2007-07-18 EP disclosed
WO-2006048308-A1 QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS ANTIMITOTICS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID DERIVATIVES EMBL (DE) 2006-05-11 WO disclosed
EP-0564397-A1 Antiatherosclerotic substituted phenylquinazoline derivatives SANDOZ LTD. (CH) 1993-10-06 EP disclosed
CN-1076445-A The phenylquinazoline derivates that replaces SANDOZ LTD (US) 1993-09-22 CN disclosed